Novartis predicts Amazon DTx delivery. VR pain relief.

Issue 016. Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 64 percent open rate. Here's what's happening this week:

Your editor is counting down the days until his son's first day of Kindergarten next month and wondering how 5.5 years went by so quickly?
Wellframe's Chief Medical Officer Dr. Trishan Panch wrote the must-read commentary this week in Nature. His argument boils down to: "The potential of AI is well described, however in reality health systems are faced with a choice: to significantly downgrade the enthusiasm regarding the potential of AI in everyday clinical practice, or to resolve issues of data ownership and trust and invest in the data infrastructure to realize it."
The founder of Cord Health, which aimed to help people with Alzheimer's or dementia, penned a particularly good post-mortem on his now

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Novartis predicts Amazon DTx delivery. VR pain relief.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.